Who Owns NervGen Pharma Stock?
NASDAQ: NGENHealth CareBiotechnology: Pharmaceutical PreparationsUSD
At close: Nov 20, 4:00 PM ET · Delayed 15 min
Ownership breakdown
- Held by institutions
- 10.30%
- Held by insiders
- 15.61%
- Institutional holders
- 73
- Institutions 10.3%
- Insiders 15.6%
- Public and other 74.1%
Who owns NervGen Pharma stock?
Institutional investors own about 10.3% of NervGen Pharma's shares, spread across 73 institutions that file 13F reports. That level of institutional ownership is relatively low, leaving more of the stock with retail investors and insiders. Insiders, including executives, directors and large founding shareholders, hold 15.61% of NGEN.
The largest institutional holders are Empery Asset Management, LP (4.10%), Rock Springs Capital Management, LP (1.50%) and Valley Forge Investment Consultants, Inc. (1.03%). Together, the top 10 institutions control 10.9% of shares outstanding. In their latest filings, 3 of the top 10 institutions increased their NGEN positions and 5 reduced them.
Summary generated from market data by MetaCap's automated system. Methodology
Top institutional holders of NGEN
| Institution | Shares | % Held | Change |
|---|---|---|---|
| Empery Asset Management, LP | 3.31M | 4.10% | -17.3% |
| Rock Springs Capital Management, LP | 1.21M | 1.50% | 0.0% |
| Valley Forge Investment Consultants, Inc. | 834.16K | 1.03% | +8241.6% |
| DAFNA Capital Management, LLC | 810.86K | 1.01% | -22.8% |
| Marshall Wace LLP | 617.25K | 0.77% | +41.6% |
| LMR Partners LLP | 550.00K | 0.68% | -8.3% |
| Ghisallo Capital Management, LLC | 500.00K | 0.62% | -50.0% |
| Two Sigma Investments, LP | 463.49K | 0.57% | +100.0% |
| UBS Group AG | 284.57K | 0.35% | -25.1% |
| Woodline Partners LP | 250.50K | 0.31% | 0.0% |
% held is the share of total shares outstanding. Change is the percentage change in the position since the holder's previous 13F filing.
Top mutual fund and ETF holders of NGEN
| Fund | Shares | % Held |
|---|---|---|
| Fidelity Concord Street Trust-Fidelity Nasdaq Composite Index Fund | 67.45K | 0.08% |
| SPDR INDEX SHARES Fd.S-State Street SPDR S&P Intl Small Cap ETF | 61.30K | 0.08% |
| iShares Trust-iShares Neuroscience and Healthcare ETF | 8.26K | 0.01% |
Frequently asked questions
Who is the largest shareholder of NervGen Pharma?
Empery Asset Management, LP is the largest institutional shareholder of NGEN, owning 4.10% of shares outstanding (3.31M shares) as of its latest 13F filing.
What percentage of NervGen Pharma is owned by institutions?
Institutions own about 10.3% of NGEN shares and 12.2% of the public float.
How much of NervGen Pharma do insiders own?
Insiders, such as officers and directors, own about 15.61% of NGEN shares outstanding.
Where does institutional ownership data come from?
Investment managers with more than $100 million in US equities must file Form 13F with the SEC within 45 days of each quarter-end. Holdings are therefore up to about 4.5 months old when published.